Navigation Links
Cancer drug shortages mean higher costs and greater risk for patients
Date:3/21/2013

included time spent trying to find scarce medications to purchase or identify alternatives. Eighty-five percent of respondents reported shortages led to higher medical costs.

Drug shortages also disrupted the clinical trials that are essential for developing new cancer treatments. This survey found that shortages forced 44 percent of institutions to either halt or delay enrollment in clinical trials. The problem also led some providers to change or omit medications.

In this survey, the drugs most frequently reported as being in short supply were fluorouracil, leucovorin, liposomal doxorubicin and paclitaxel. Such shortages hit patients battling ovarian, breast and colorectal cancers particularly hard. For some patients, the survey found shortages meant traveling to other institutions for treatment or receiving alternative medications. For other patients, it meant treatment was delayed or continued with either lower doses of the missing drugs or without the drugs at all.

Ali McBride , Pharm.D., The Ohio State University, is the first and corresponding author. Other authors are Lisa Holle , University of Connecticut; Colleen Westendorf , formerly of University of Kentucky and now of St. Jude; Margaret Sidebottom and Niesha Griffith , Ohio State; and Raymond Muller , Memorial Sloan-Kettering Cancer Center, New York.

The study was funded in part by a grant (CA21765) from the National Institutes of Health and ALSAC.

St. Jude Children's Research Hospital
St. Jude Children's Research Hospital is internationally recognized for its pioneering research and treatment of children with cancer and other life-threatening diseases. The hospital's research has helped push overall survival rates for childhood cancer from less than 20 percent
'/>"/>

SOURCE St. Jude Children's Research Hospital
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Lung Cancer Alliance Congratulates 75 Medical Centers For Moving Swiftly And Responsibly On Lung Cancer Screening
2. VeriStrat® Test Results Correlate with Survival Outcomes in Advanced Lung Cancer
3. OncoSec ElectroChemotherapy Demonstrates Potential as Alternative to Surgery for Treating Head and Neck Cancer
4. New Veridex Alliance Drives Study Of Circulating Tumor Cells In Men With Metastatic Prostate Cancer
5. Novelos Therapeutics Announces Successful Completion of First Cohort In Lung Cancer Trial With I-124-CLR1404 (LIGHT) Cancer-Targeted PET Imaging Agent at UW Carbone Cancer Center
6. Accuray Launches First Study to Compare CyberKnife® SBRT to Surgery and IMRT for Treatment of Early-Stage Prostate Cancer
7. Elekta, pioneer in treatment of cancer in brain disorders, to Move North America Headquarters to Atlanta
8. Inovio Pharmaceuticals Granted U.S. Patent Protection for Synthetic Vaccine for Cervical Dysplasia and Cancer
9. National Jewish Health, the Nations Premier Respiratory Hospital, Announces Lung Cancer Screening Trial Using Blood Test and CT
10. Retrospective Study Suggests that Stereotactic Ablative Radiotherapy (SABR) Can be a Viable Option for Treating Early-Stage Lung Cancer in Operable as well as Inoperable Patients; Phase III Randomized Trial Now Under Way
11. National Patient Advocate Foundation Praises Signing of the Delaware Cancer Treatment Access Act into Law
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... OAKS, Calif. , June 19, 2013 Amgen ... the United States , Canada ... this year,s recipients of the Amgen Award for Science Teaching ... extraordinary teachers at the kindergarten through 12th grade level who ... in science education. With a long-standing commitment to ...
(Date:6/19/2013)... Pharmacyclics, Inc. (the "Company") (Nasdaq: ... Journal of Medicine ( NEJM ) published results ... oral Bruton,s tyrosine kinase (BTK) inhibitor ibrutinib in patients ... lymphoma (SLL). Ibrutinib was shown to be safe and ... in patients who were at high-risk due to factors ...
(Date:6/19/2013)...   NextDocs announced today that it will ... at DIA 2013 , the Drug Information Association ... studies that explore best practices for making the transition ... file (eTMF) systems. Sharon Ames , ... Krystyna Kowalczyk , executive vice president of clinical operations ...
Breaking Medicine Technology:Amgen Award For Science Teaching Excellence Honors Outstanding Teachers 2Amgen Award For Science Teaching Excellence Honors Outstanding Teachers 3Ibrutinib Study Results in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia Published in The New England Journal of Medicine 2Ibrutinib Study Results in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia Published in The New England Journal of Medicine 3Ibrutinib Study Results in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia Published in The New England Journal of Medicine 4Ibrutinib Study Results in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia Published in The New England Journal of Medicine 5Ibrutinib Study Results in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia Published in The New England Journal of Medicine 6NextDocs and Novella to Present on eTMF at DIA 2013 2
(Date:6/19/2013)... STRATFORD, Conn (PRWEB) June 20, 2013 A man ... same man he used to be. In his debut book titled ... a war veteran who immerses himself back home, looking for the ... When Gabriel De Los Angeles, former marine from the Vietnam War, ... to take the edge off his PTSD. Wings, a wealthy acquaintance ...
(Date:6/19/2013)... Across the globe billions of people live ... the medical advances that benefit developed western society. ... and the necessary aid to help curb the conditions ... Outlook with Ben Kingsley is partnering with some ... these people live and highlight the invaluable resources being ...
(Date:6/19/2013)... 2013 HASCO Medical, Inc. (OTCBB: ... intent to purchase privately held Auto Mobility Sales, ... wheelchair accessible vehicle sales, service and rentals in ... Inc compliments and expands HASCO's strategy of becoming ... dealers . The acquisition is subject to customary ...
(Date:6/19/2013)... 2013 Kleritec, Inc. announced the addition ... http://www.kleritec.com . In the recent expansion Kleritec ... activities packages for pre-school and day care providers. The ... to aid teachers across the United States the ability ... , Included in the art and activities packages is ...
(Date:6/19/2013)... Citi Bike has come to New York City in ... to know for sure how many patients will choose to take ... the option. In fact, he’s happy about anything that might ... it more convenient for them to visit his office at 133 ... Alternative Medicine at Back and Body Medical and an experienced ...
Breaking Medicine News(10 mins):Health News:Rafael Fragauda’s New Book Underlines Post Traumatic Stress Disorder 2Health News:HASCO Medical, Inc. to Acquire Auto Mobility Sales, Inc. 2Health News:Kleritec Announces Addition of Educational Products. 2Health News:New York City's Back and Body Medical Welcomes Citi Bike to Midtown Manhattan 2Health News:New York City's Back and Body Medical Welcomes Citi Bike to Midtown Manhattan 3
... Cuts Will Reduce Access to Care for Millions ... , , ARLINGTON, Va., Sept. 16 ... recommendations for healthcare reform in his long-awaited "Chairman,s mark" version of ... home medical equipment, ranging from power wheelchairs to anti-fraud measures. The ...
... strong disapproval of contraception might be a factor , ... are higher in states with greater levels of religious ... new U.S. study suggests. , In the study, researchers ... on teen birth rates with data from the Pew ...
... , PANAMA CITY, Fla., Sept. 16 ... staff washing their hands when moving from patient to patient can ... Commission , handwashing failures contribute to healthcare-associated infections ... hospitals $4 billion to $29 billion annually to combat. At ...
... , MINNEAPOLIS, Sept. 16 Today ClearWay ... and thanked outgoing members for their service to the organization. David ... as the new Board Chair. The full roster of Board Officers ... David Fisher, Board Chair - An attorney ...
... , , , SAN DIEGO, ... Diego based medical device company, today announced that its application for ... technology has been approved by the Food and Drug Administration. The ... , , Jim Hitchin, SpectraScience,s, CEO said, ...
... InVitria to ... in Animal Cells (PEACe) in Jackson Hole, WY, Sept. 19-23. , ... Fort Collins, CO (PRWEB) September 16, 2009 -- InVitria ... supplements at the 9th Annual PEACe conference to be held in Jackson Hole, WY, Sept. ...
Cached Medicine News:Health News:Senate Finance Committee Cuts Home Medical Equipment in Reform Package 2Health News:Bay Medical Fights Healthcare-Associated Infections by Improving Hand Hygiene 300% 2Health News:Bay Medical Fights Healthcare-Associated Infections by Improving Hand Hygiene 300% 3Health News:Bay Medical Fights Healthcare-Associated Infections by Improving Hand Hygiene 300% 4Health News:ClearWay Minnesota(SM) Board Approves New Officers 2Health News:SpectraScience Receives FDA Approval for Enhancements to WavSTAT(R) Optical Biopsy System 2Health News:InVitria Cell Culture Product Line to Headline PEACe 2
... 1 Block MBS Start up kit. ... software and choice of 1 MultiBlock ... to 30 blocks. User friendly software. ... Adjustable height heated lid. Outstanding ...
0.2ml Gradient Block MBSR. Robot compatible block ejection mechanism. Stackable. (96 well block - holds 1 plate 0.2ml x 96 well plate)...
96 well format, Gradient features tests 12 PCR annealing temperatures in 1 run...
... The latest addition to our ... cyclers is the personal-sized GeneAmp ... instrument for both basic PCR ... represents the culmination of several ...
Medicine Products: